- Home
- FEMY vs MRM Comparison
FEMY vs MRM Comparison
Compare FEMY & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- MRM
- Stock Information
- Founded
- FEMY 2004
- MRM 2000
- Country
- FEMY United States
- MRM Japan
- Employees
- FEMY N/A
- MRM N/A
- Industry
- FEMY Medical/Dental Instruments
- MRM Other Consumer Services
- Sector
- FEMY Health Care
- MRM Consumer Discretionary
- Exchange
- FEMY Nasdaq
- MRM Nasdaq
- Market Cap
- FEMY 12.5M
- MRM 10.4M
- IPO Year
- FEMY 2021
- MRM 2020
- Fundamental
- Price
- FEMY $0.60
- MRM $2.03
- Analyst Decision
- FEMY Strong Buy
- MRM
- Analyst Count
- FEMY 3
- MRM 0
- Target Price
- FEMY $7.33
- MRM N/A
- AVG Volume (30 Days)
- FEMY 6.9M
- MRM 5.2M
- Earning Date
- FEMY 11-11-2025
- MRM 11-11-2025
- Dividend Yield
- FEMY N/A
- MRM N/A
- EPS Growth
- FEMY N/A
- MRM 27.65
- EPS
- FEMY N/A
- MRM 0.18
- Revenue
- FEMY $1,887,016.00
- MRM $52,786,758.00
- Revenue This Year
- FEMY $103.55
- MRM N/A
- Revenue Next Year
- FEMY $148.13
- MRM N/A
- P/E Ratio
- FEMY N/A
- MRM $10.53
- Revenue Growth
- FEMY 98.61
- MRM 21.55
- 52 Week Low
- FEMY $0.31
- MRM $0.34
- 52 Week High
- FEMY $1.80
- MRM $5.30
- Technical
- Relative Strength Index (RSI)
- FEMY 59.98
- MRM 50.15
- Support Level
- FEMY $0.34
- MRM $1.95
- Resistance Level
- FEMY $0.92
- MRM $2.32
- Average True Range (ATR)
- FEMY 0.06
- MRM 0.32
- MACD
- FEMY 0.05
- MRM -0.01
- Stochastic Oscillator
- FEMY 50.50
- MRM 15.38
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.